BMPR1a Is Required for the Optimal TGFβ1-Dependent CD207


Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
09 2022
Historique:
received: 24 11 2021
revised: 08 02 2022
accepted: 21 02 2022
pubmed: 19 3 2022
medline: 24 8 2022
entrez: 18 3 2022
Statut: ppublish

Résumé

The cytokine TGFβ1 induces epidermal Langerhans cell (LC) differentiation from human precursors, an effect mediated through BMPR1a/ALK3 signaling, as revealed from ectopic expression and receptor inhibition studies. Whether TGFβ1‒BMPR1a signaling is required for LC differentiation in vivo remained incompletely understood. We found that TGFβ1-deficient mice show defective perinatal expansion and differentiation of LCs. LCs can be identified within the normal healthy human epidermis by anti-BMPR1a immunohistology staining. Deletion of BMPR1a in all (vav

Identifiants

pubmed: 35300973
pii: S0022-202X(22)00195-6
doi: 10.1016/j.jid.2022.02.014
pii:
doi:

Substances chimiques

Antigens, CD 0
Antigens, Surface 0
CD11 Antigens 0
CD11c Antigen 0
Cd207 protein, mouse 0
Itgax protein, mouse 0
Lectins, C-Type 0
Mannose-Binding Lectins 0
Bmpr1a protein, mouse EC 2.7.11.30
Bone Morphogenetic Protein Receptors, Type I EC 2.7.11.30

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2446-2454.e3

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Mathias Hochgerner (M)

Division of Immunology and Pathophysiology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria; Center for Cancer Research, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Vienna, Austria.

Thomas Bauer (T)

Center for Cancer Research, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Vienna, Austria.

Victoria Zyulina (V)

Division of Immunology and Pathophysiology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.

Elisabeth Glitzner (E)

Center for Cancer Research, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Vienna, Austria.

Sarah Warsi (S)

Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University Hospital, Lund, Sweden.

Joanne E Konkel (JE)

Mucosal Immunology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA; The Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.

Carmen Tam-Amersdorfer (C)

Division of Immunology and Pathophysiology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.

Wanjun Chen (W)

Mucosal Immunology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.

Stefan Karlsson (S)

Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University Hospital, Lund, Sweden.

Maria Sibilia (M)

Center for Cancer Research, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Vienna, Austria.

Herbert Strobl (H)

Division of Immunology and Pathophysiology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria. Electronic address: herbert.strobl@medunigraz.at.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation

Classifications MeSH